0001567619-21-014512.txt : 20210805 0001567619-21-014512.hdr.sgml : 20210805 20210805170138 ACCESSION NUMBER: 0001567619-21-014512 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210803 FILED AS OF DATE: 20210805 DATE AS OF CHANGE: 20210805 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lane Michael CENTRAL INDEX KEY: 0001740689 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 211149265 MAIL ADDRESS: STREET 1: C/O IDEXX LABORATORIES, INC. CITY: WESTBROOK STATE: ME ZIP: 04092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 doc1.xml FORM 4 X0306 4 2021-08-03 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001740689 Lane Michael C/O IDEXX LABORATORIES, INC. ONE IDEXX DRIVE WESTBROOK ME 04092 0 1 0 0 Executive Vice President Common Stock 2021-08-03 4 M 0 1472 67.85 A 5119.2845 D Common Stock 2021-08-03 4 M 0 1091 67.85 A 6210.2845 D Common Stock 2021-08-03 4 M 0 4436 141.6 A 10646.2845 D Common Stock 2021-08-03 4 S 0 2451 690.1997 D 8195.2845 D Common Stock 2021-08-03 4 S 0 250 691.5368 D 7945.2845 D Common Stock 2021-08-03 4 S 0 363 692.8467 D 7582.2845 D Common Stock 2021-08-03 4 S 0 1447 693.7287 D 6135.2845 D Common Stock 2021-08-03 4 S 0 916 694.7894 D 5219.2845 D Common Stock 2021-08-03 4 S 0 100 695.5 D 5119.2845 D Common Stock 2021-08-03 4 S 0 95 687.4650 D 5024.2845 D Common Stock 2021-08-03 4 S 0 245 688.5444 D 4779.2845 D Common Stock 2021-08-03 4 S 0 245 689.4310 D 4534.2845 D Common Stock 2021-08-03 4 S 0 30 690.3250 D 4504.2845 D Common Stock 2021-08-03 4 S 0 100 691.3520 D 4404.2845 D Common Stock 2021-08-03 4 S 0 60 692.6466 D 4344.2845 D Common Stock 2021-08-03 4 S 0 84 687.5931 D 4280.2845 D Common Stock 2021-08-03 4 S 0 299 688.5104 D 3961.2845 D Common Stock 2021-08-03 4 S 0 153 689.5101 D 3808.2845 D Common Stock 2021-08-03 4 S 0 100 691.192 D 3708.2845 D Common Stock 2021-08-03 4 S 0 60 692.5616 D 3648.2845 D Common Stock 2021-08-03 4 S 0 1 693.17 D 3647.2845 D Common Stock 592 I by spouse Incentive Stock Option (right-to-buy) 67.85 2021-08-03 4 M 0 1472 D 2026-02-13 Common Stock 1472 462 D Non-Qualified Stock Option (right-to-buy) 67.85 2021-08-03 4 M 0 1091 D 2026-02-13 Common Stock 1091 0 D Non-Qualified Stock Option (right-to-buy) 141.60 2021-08-03 4 M 0 4436 D 2027-02-13 Common Stock 4436 1512 D Includes a total of 23.2845 shares of common stock acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on March 31, 2021 and June 30, 2021. Represents the weighted average sales price of the shares sold ranging from a low of $690.00 to a high of $690.965 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Represents the weighted average sales price of the shares sold ranging from a low of $691.085 to a high of $692.08 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Represents the weighted average sales price of the shares sold ranging from a low of $692.33 to a high of $693.26 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Represents the weighted average sales price of the shares sold ranging from a low of $693.38 to a high of $694.38 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Represents the weighted average sales price of the shares sold ranging from a low of $694.49 to a high of $695.375 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Represents the weighted average sales price of the shares sold ranging from a low of $686.91 to a high of $687.90 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Represents the weighted average sales price of the shares sold ranging from a low of $688.07 to a high of $688.96 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Represents the weighted average sales price of the shares sold ranging from a low of $689.14 to a high of $690 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Represents the weighted average sales price of the shares sold ranging from a low of $690.17 to a high of $690.48 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Represents the weighted average sales price of the shares sold ranging from a low of $691.19 to a high of $691.45 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Represents the weighted average sales price of the shares sold ranging from a low of $692.27 to a high of $692.96 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Represents the weighted average sales price of the shares sold ranging from a low of $687.05 to a high of $687.83 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Represents the weighted average sales price of the shares sold ranging from a low of $688.09 to a high of $688.97 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Represents the weighted average sales price of the shares sold ranging from a low of $689.25 to a high of $690.18 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Represents the weighted average sales price of the shares sold ranging from a low of $690.45 to a high of $691.45 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Represents the weighted average sales price of the shares sold ranging from a low of $692.125 to a high of $692.85 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Held by the reporting person's spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein. Grant of option to buy 2,072 shares of Issuer common stock that vested in five annual installments beginning February 14, 2017. Grant of option to buy 10,749 shares of Issuer common stock that vested in five annual installments beginning February 14, 2017. Grant of option to buy 10,386 shares of Issuer common stock that vest in five annual installments beginning February 14, 2018. Not applicable. /s/ Lily J. Lu, Attorney-in-Fact for Michael Lane 2021-08-05